Puma Biotechnology Inc
Puma Biotechnology Inc (PBYI) Straddle
PBYI straddle scan found 6 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 43.9%.
Read more
Trading a PBYI straddle lets you take a pure volatility position on Puma Biotechnology Inc without committing to a direction. Puma Biotechnology Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate PBYI straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on PBYI profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Puma Biotechnology Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the PBYI straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd.
The company was founded in 2010 and is headquartered in Los Angeles, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the PBYI straddle is the cleanest expression of that view. Our scanner prices every PBYI straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a PBYI straddle into a catalyst or short a PBYI straddle to harvest decay, the options straddle setups that matter are all in one place.
| Dec 18, 2026 | 15.00 | $5.60 | 84 | 1% | 43.9% | $20.60 | $9.40 | 1 |
| Mar 19, 2027 | 15.00 | $6.48 | 175 | 1% | 33.8% | $21.48 | $8.53 | 1 |
| Nov 20, 2026 | 12.50 | $3.73 | 56 | 1% | 26.0% | $16.23 | $8.78 | 0 |
| Nov 20, 2026 | 10.00 | $2.08 | 56 | 1% | 18.1% | $12.08 | $7.93 | 0 |
| Mar 19, 2027 | 10.00 | $3.60 | 175 | 1% | 17.7% | $13.60 | $6.40 | 5 |
| Dec 18, 2026 | 10.00 | $3.75 | 84 | 1% | 4.6% | $13.75 | $6.25 | 0 |
As of September 25, 2026
Find the right straddle before volatility moves
Track PBYI straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→